Saturday 17 October 2026 Export GNPX’s income statement to Excel — free account

GENPREX

GNPX Healthcare Biotechnology

In the quarter to June 2026, EPS grew 95.0% and free cash flow fell 33.0%, each against the same quarter a year earlier.

2.11 0.18 −7.86%

Follow GNPX

Alert me

Market cap: $1.9M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	(1,378.59%)	(338.73%)	(160.84%)	(203.86%)
ROA Full definition →		(448.99%)	(227.24%)	(127.12%)	(157.40%)
ROIC Full definition →		0.00%	(7,402.48%)	0.00%	0.00%
Return on Tangible Assets Full definition →		2,004.45%	(262.51%)	(108.26%)	(122.20%)
Average Days of Receivables Full definition →		—	—	—	—
Free Cash Flow per Share Full definition →		(435.91)	(360.26)	(45.17)	(32.90)
Free Cash Flow Full definition →		(15.08)	(15.31)	(14.29)	(15.56)
Other line items
Cash ROIC Full definition →		(806.07%)	(96.95%)	(40.85%)	(51.96%)
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →		0.90	0.94	0.85	0.94
Revenue per Share Full definition →		0.00	0.00	0.00	0.00
Operating CF per Share Full definition →		(435.91)	(360.26)	(45.17)	(32.90)
Capex per Share Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates